Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Orthofix Medical (OFIX) EBT (2016 - 2026)

Orthofix Medical has reported EBT over the past 17 years, most recently at -$20.8 million for Q1 2026.

  • For the quarter ending Q1 2026, EBT rose 60.04% year-over-year to -$20.8 million, compared with a TTM value of $33.8 million through Mar 2026, up 123.97%, and an annual FY2025 reading of $2.5 million, up 101.99% over the prior year.
  • EBT came in at -$20.8 million for Q1 2026, down from $91.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $132.7 million in Q4 2023 to a low of -$60.3 million in Q1 2023.
  • Median EBT over the past 5 years was -$22.3 million (2025), compared with a mean of -$9.0 million.
  • The largest YoY upside for EBT was 1999.89% in 2023 against a maximum downside of 1346.48% in 2023.
  • Over 5 years, EBT stood at -$7.0 million in 2022, then soared by 1999.89% to $132.7 million in 2023, then plummeted by 122.38% to -$29.7 million in 2024, then surged by 406.57% to $91.1 million in 2025, then tumbled by 122.87% to -$20.8 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's EBT are -$20.8 million (Q1 2026), $91.1 million (Q4 2025), and -$22.3 million (Q3 2025).